Arrowhead Pharmaceuticals Inc. buy Sumitomo Mitsui Financial Group, Inc.
Start price
26.04.23
/
50%
€30.42
Target price
26.04.24
€72.10
Performance (%)
-32.54%
End price
27.04.24
€20.52
Summary
This prediction ended on 27.04.24 with a price of €20.52. Massive losses of -32.54% were the result for the BUY prediction by Sumitomo_Mitsui_Fina. Sumitomo_Mitsui_Fina has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arrowhead Pharmaceuticals Inc. | 12.622% | 12.622% | -30.348% |
iShares Core DAX® | 0.051% | 5.593% | 14.403% |
iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% |
iShares Nikkei 225® | 2.181% | 2.815% | 11.116% |
iShares S&P 500 | 1.040% | 4.975% | 27.631% |
Comments by Sumitomo_Mitsui_Fina for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is now covered by analysts at Sumitomo Mitsui Financial Group, Inc.. They set an "outperform" rating and a $80.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Sumitomo_Mitsui_Fina gewählte maximale Laufzeit wurde überschritten